This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Biotech & Crypto -- Best ETF Areas of Last Week
by Sanghamitra Saha
Biotech and cryptocurrency -- two ETF areas outperformed last week.
Tech ETFs Make A Solid Comeback in July
by Sweta Killa
A drop in Treasury yields, which had led to a sell-off in the tech sector, and declining commodity prices brought back the lure for tech stocks.
5 ETFs Up in Double-Digits Post Fed's Fourth Rate Hike
by Sweta Killa
Wall Street rallied on Wednesday following the Fed's fourth consecutive rate hike decision. The tech-heavy Nasdaq Composite Index had its biggest one-day percentage gain in more than two years.
Pain Ahead for Bitcoin & Related ETFs?
by Sanghamitra Saha
Electric car maker Tesla (TSLA) sold $936 million worth of bitcoin during the second quarter.
5 ETFs Taking Charge of the Ongoing Rally
by Sweta Killa
The U.S. stock market was off to a strong start in July. A strong jobs report, a better-than-expected Q2 earnings picture and a drop in commodity prices brought back the lure for riskier assets.
Tech ETFs At the Forefront of the Rally Last Week
by Sweta Killa
The U.S. stock market was off to a strong start in July as strong jobs report and drop in commodity prices brought back the lure for riskier assets.
5 ETFs That Gained Double Digits in Thursday's Session
by Sweta Killa
U.S. stock markets have stabilized in July, with all three gauges notching their fourth consecutive wins.
Bitcoin to Soar 40% to $28K by Year-End? ETFs to Play
by Sanghamitra Saha
analysts at Deutsche Bank expect bitcoin to rally to $28K by this year-end. Should you tap the crypto-focused funds?
Best & Worst Performing ETFs of 1H22
by Neena Mishra
We take a look at ETF areas that delivered best and worst returns during the first half of 2022
5 ETFs That Gained in Tuesday's Trading Session
by Sweta Killa
Wall Street rally was driven by bargain hunting as most investors flocked in to take advantage of equity weakness and extreme oversold condition.